KSKathryn Berrier Sheets

Kathryn Berrier Sheets

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kathryn Berrier Sheets has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • Campbell K. Brasington

    3 shared publications
  • Zoheb B. Kazi

    Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA

    3 shared publications
  • Alison Schwartz

    Down Syndrome Program, Division of Genetics, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts

    2 shared publications
  • Angela Lombardo

    Down Syndrome Program, Division of Developmental Medicine, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts

    2 shared publications
  • Blythe Crissman

    Comprehensive Down Syndrome Program, Division of Medical Genetics, Duke University Medical Center, Durham, North Carolina

    2 shared publications
  • Brian G. Skotko

    Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA

    2 shared publications

Latest Publications

  • Thyroid dysfunction in patients with Down syndrome: Results from a multi‐institutional registry study

    by Jenifer Lavigne, Christianne Sharr, Ibrahim Elsharkawi, Al Ozonoff, Nicole Baumer, Campbell Brasington, Sheila Cannon, Blythe Crissman, Emily Davidson, Jose C. Florez, et al.

    The goals of this undertaking were to assess the outcomes of thyroid screening tests and adherence to thyroid screening guidelines across five Down syndrome (DS) specialty clinics in various states. Data related to thyroid screening were collected for 663 individuals across five clinics specializing in the comprehensive care of individuals with DS for a period of 1 year. Of the 663 participants, 47.7% of participants had a TSH and free T4 ordered at their DS specialty clinic visit. Approximately 19.0% (60/316) had a new thyroid disorder diagnosis made. We conclude that a sizable proportion of the patients with DS are not up‐to‐date on current guidelines when they present to a DS specialty clinic, while adherence to thyroid screening guidelines helps facilitate early diagnoses. Hypothyroidism is prevalent in the population, consistent with reported literature. DS specialty clinics can help patients stay current on screening guidelines.


  • National down syndrome patient database: Insights from the development of a multi‐center registry study

    by Jenifer Lavigne, Christianne Sharr, Al Ozonoff, Lisa Albers Prock, Nicole Baumer, Campbell Brasington, Sheila Cannon, Blythe Crissman, Emily Davidson, Jose C. Florez, et al.

    The Down Syndrome Study Group (DSSG) was founded in 2012 as a voluntary, collaborative effort with the goal of supporting evidenced‐based health care guidelines for individuals with Down syndrome (DS). Since then, 5 DS specialty clinics have collected prospective, longitudinal data on medical conditions that co‐occur with DS. Data were entered by clinical staff or trained designees into the National Down Syndrome Patient Database, which we created using REDCap software. In our pilot year, we enrolled 663 participants across the U.S., ages 36 days to 70 years, from multiple racial and ethnic backgrounds. Here we report: (i) the demographic distribution of participants enrolled, (ii) a detailed account of our database infrastructure, and (iii) lessons learned during our pilot year to assist future researchers with similar goals for other patient populations.


  • CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy

    by Kathryn L. Berrier, Zoheb B. Kazi, Sean N. Prater, Deeksha S. Bali, Jennifer Goldstein, Mihaela C. Stefanescu, Catherine W. Rehder, Eleanor G. Botha, Carolyn Ellaway, Kaustuv Bhattacharya, et al.


  • Consideration of increased dosing of alglucosidase alfa to achieve improved clinical outcomes in infantile Pompe disease

    by Sean N. Prater, Kathryn Berrier Sheets, Sarah Young, Katherine Kim, Barbara Burton, Priya S. Kishnani


  • Prophylactic immume modulation in infantile Pompe disease: Collective experience treating CRIM-positive and negative patients in the naive setting

    by Priya S. Kishnani, Kathryn Berrier Sheets, Zoheb Kazi, Stephanie DeArmey, Deeksha Bali, Amy Rosenberg

  • Discordant clinical responses in CRIM-positive IPD siblings demonstrate need for prophylactic ITI in the naive setting

    by Kathryn Berrier Sheets, Zoheb Kazi, Stephanie DeArmey, Emily Lisi, Elizabeth Stenger, Priya S. Kishnani


  • Balanced Information About Down Syndrome: What Is Essential?

    by Kathryn B. Sheets, Robert G. Best, Campbell K. Brasington, Madeleine C. Will

    The first information given to parents of children with newly diagnosed Down syndrome has a major impact on adaptation to the diagnosis and subsequent decision making. It is generally recommended that the information provided by genetic counselors be balanced, with positive and negative information. However, few studies have defined what “balanced” means, and genetic counselors and parents may have a different perspective with regard to the information needed. Prior studies evaluating types of information provided about Down syndrome by genetic counselors have not considered the information that parents of children with newly diagnosed Down syndrome believe to be important. This report used an online survey to examine the perspectives of genetic counselors and parents to establish a general consensus on the essential information that should be provided during initial discussion of a newly diagnosed Down syndrome in both prenatal and postnatal settings. Genetic counselors and parents were identified and surveyed through online contact with members of the National Down Syndrome Congress, National Down Syndrome Society, and National Society of Genetic Counselors. Of the total of 993 parents and 389 genetic counselors who started the online survey, 687 parents (69.2%) and 254 genetic counselors (65.2%) completed all sections. Participants rated each of 100 features of Down syndrome as essential, important but not essential, or not too important for the initial discussion of a diagnosis. The responses of parents and genetic counselors identified a total of 34 essential informational items to include. Essential items included how the diagnosis was made, clinical features, associated medical complications, available therapies, prognosis for intellectual disability, a range of potential outcomes, and informational resources and referrals. In addition to these 34 essential items, survey responses showed parents value information demonstrating the abilities and potentials of people with Down syndrome and that illustrate what life is like for a child and adult with Down syndrome. These findings show that to facilitate adaptation by families of affected infants to a new diagnosis of Down syndrome, the initial pre- and postnatal discussion should balance clinical information with the information that parents believe to be important.

  • Practice Guidelines for Communicating a Prenatal or Postnatal Diagnosis of Down Syndrome: Recommendations of the National Society of Genetic Counselors

    by Kathryn B. Sheets, Blythe G. Crissman, Cori D. Feist, Susan L. Sell, Lisa R. Johnson, Kelly C. Donahue, Diane Masser‐Frye, Gail S. Brookshire, Amanda M. Carre, Danielle LaGrave, et al.

    Down syndrome is one of the most common conditions encountered in the genetics clinic. Due to improvements in healthcare, educational opportunities, and community inclusion over the past 30 years, the life expectancy and quality of life for individuals with Down syndrome have significantly improved. As prenatal screening and diagnostic techniques have become more enhanced and widely available, genetic counselors can expect to frequently provide information and support following a new diagnosis of Down syndrome. This guideline was written for genetic counselors and other healthcare providers regarding the communication of a diagnosis of Down syndrome to ensure that families are consistently given up‐to‐date and balanced information about the condition, delivered in a supportive and respectful manner.


  • Balanced information about Down syndrome: What is essential?

    by Kathryn B. Sheets, Robert G. Best, Campbell K. Brasington, Madeleine C. Will

    The purpose of this study was to explore the perspectives of genetic counselors and parents of children with Down syndrome to define essential information for the initial discussion of a new diagnosis. We compared information given in both prenatal and postnatal settings, and also aimed to distinguish differences between the informational needs of parents and the information genetic counselors provide. Online surveys were distributed to members of the National Down Syndrome Congress, National Down Syndrome Society, and National Society of Genetic Counselors. Participants included 993 parents of children with Down syndrome and 389 genetic counselors. Participants rated 100 informational features about Down syndrome as Essential, Important, or Not Too Important for inclusion in the first discussion of the diagnosis. Responses identified 34 essential informational items for the initial discussion of Down syndrome, including clinical features, developmental abilities, a range of prognostications, and informational resources. Healthcare providers should consider incorporating these items in their initial discussion of a diagnosis in both prenatal and postnatal settings. Statistically significant differences between parent and genetic counselor responses illustrate that information is valued differently and that parents appreciate information about the abilities and potential of people with Down syndrome, as opposed to clinical details. Balancing clinical information with other aspects of the condition, as well as a better understanding of the information parents consider most important, may enable healthcare professionals to more effectively satisfy families' informational needs following a new diagnosis of Down syndrome.